Calcium antagonists for aneurysmal subarachnoid haemorrhage
about
Antiplatelet therapy for aneurysmal subarachnoid haemorrhageCalcium antagonists for aneurysmal subarachnoid haemorrhageGenes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleedingImpact of heme and heme degradation products on vascular diameter in mouse visual cortexAxonal damage and outcome in subarachnoid haemorrhage.Impact of Comorbidity on Early Outcome of Patients with Subarachnoid Hemorrhage Caused by Cerebral Aneurysm Rupture.Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhageIntraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage.Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage.Prevention of delayed cerebral ischaemia after subarachnoid haemorrhageNimodipine Ophthalmic Formulations for Management of Glaucoma.Calcium antagonism in neonatal rats with kaolin-induced hydrocephalus.Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.Determinants of human cerebral pressure-flow velocity relationships: new insights from vascular modelling and Ca²⁺ channel blockade.Subarachnoid haemorrhage
P2860
Q24243050-517C5183-1FFB-4B3B-8031-1317D8E7FFA9Q24244167-D7C66790-EC83-4151-89F9-52636ADD0F74Q33626060-B6466142-02BD-4616-A730-7BE1744DC38DQ35026447-49C5AA36-11C2-4A49-B469-09E5607BE65AQ36142095-472BFEB1-ED85-407A-993B-5205912B8678Q36264572-7E012689-D035-4F11-BC05-1BC4020CC635Q36392740-F67E9891-C4C6-4FC8-B8F3-0B6315342CBFQ37392447-7AC82520-C2C3-437F-A0D3-6E3CB2B11045Q37721455-EC64E19D-4477-43D2-B78A-04BF4EA8CDBFQ38690003-EF84CB86-5335-42E5-AFA6-46669F9A633DQ40980336-8B9A8558-E0A4-4C57-90B8-30E6ECE7F5BDQ41379846-6CB05F19-6022-4C97-8A67-F6E88E3C3ED2Q42718379-7C22CA4A-7A2F-4762-A569-05A4176519ABQ46393407-AA8910A0-2E86-490F-98A3-2077B9E6B874Q46947671-560E6153-B2FA-44E4-BAB7-83994B4F6CAFQ48124048-40122BC3-C47F-4F06-8FED-9A9773AD02CEQ48266718-3721708F-F4BD-4E7E-87D8-1456969183C8Q57384716-C3098191-2051-4603-9F35-2667185B8090
P2860
Calcium antagonists for aneurysmal subarachnoid haemorrhage
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@ast
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en-gb
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@nl
type
label
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@ast
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en-gb
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@nl
prefLabel
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@ast
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en-gb
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@nl
P2093
P2860
P1476
Calcium antagonists for aneurysmal subarachnoid haemorrhage
@en
P2093
GJE Rinkel
J van Gijn
M Vermeulen
WM van den Bergh
P2860
P356
10.1002/14651858.CD000277.PUB2
P577
2005-01-24T00:00:00Z